Edwards Lifesciences - the leader in heart valves & hemodynamic ...
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Edwards Lifesciences Corp - Overview
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most.
Engineering Internship, Summer 2025 - Job Details
This posting is submitted in anticipation of future roles at Edwards. **Application deadline: February 16, 2025, at 11:59 pm PT. Program participants will work in our corporate headquarters in Irvine, California or manufacturing facility in Draper, Utah.
Newsroom - Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most.
Contact Us - Edwards Lifesciences
Discover all of our products and services designed to fit your needs.
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued …
Nov 25, 2024 · LONDON--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular …
Edwards Lifesciences to Sell Critical Care to BD
Jun 3, 2024 · IRVINE, CA--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of …
Edwards Lifesciences Outlines Growth Strategy at Annual Investor ...
Dec 4, 2024 · NEW YORK--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its first full year as a purely structural heart …
Who We Are - Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan ...
Jan 7, 2025 · Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the …